TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Functional recovery date
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence Rate Per Year of Confirmed HIV-1 Infection
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who Discontinued Blinded Study Treatment Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of IDEAL-IQ sequence of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of T1WI sequence of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of DWI sequence of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of ADC map of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in range of motion measures from standardized flexibility tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting-state electroencephalography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in subjective scores (self-reports on numeric rating scales)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-operative refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in the Mean Participant Knowledge Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Activities-specific Balance Confidence Scale (ABC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BLS skill assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean use time of the wearable sensor
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of Persisting Post-Concussion Symptoms (PPCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid profile markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hemostasis markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concentration changes in cytokines/ cytokine receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Retrievals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Retrievals per Hour
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of occurrence of pulmonary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of occurrence of cardiovascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Ratio of Iliac Widths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients experiencing treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Response to therapy assessed by Modified Harvey Bradshaw Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody levels in maternal serum IgG for respiratory syncytial virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Agreement among observer groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Event-Free Survival (EFS)
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of prevalent dialysis patients recruited and retained for 6 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in average mid-week predialysis potassium level during the study period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fidgety Movements in healthy, term born infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fidgety Movements in children with a range of medical complexities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-year Neurodevelopmental outcomes in healthy, term born infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-year Neurodevelopmental outcomes in children with a range of medical complexities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with spinal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Ponesimod
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under The Plasma Concentration-time Curve (AUC [0-24h]) of Ponesimod
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of emergency department and hospital visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total Tramadol consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of Stroke Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of hospitalization lasting more than 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Changes in Glucose Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Colony forming unit (CFU) counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from Visual Analog Scale (VAS) score at 6 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Exercise Adherence Scale Points at 6 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in natriuretic peptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in glycerol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Trost Test for selective control of lower extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEDI SCALE for functional performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: early independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: early ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Interleukin - 17A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Electrolytes in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood labs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Glycated haemoglobin (HbA1c) control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VTE recurrence event
Endpoint domain: Mortality/survival
Primary endpoint: Modified 1-Hour Pad Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Floor Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pelvic Floor Impact Questionnaire Short Form
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sexual Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Revised Oswestry Low Back Pain Disability Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Migraine Disability Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum tolerated dose of FH-A11KRASG12V-TCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Between-group comparisons in ACC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Between-group comparisons in vmPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Between-group comparisons in mOFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in 2-hour AUC of C-peptide response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Prognostic value of RXR-α
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of PARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of successful initiation and maintenance of hemodynamic support without Severe Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Rocatinlimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of device-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Induction compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient Knowledge Survey Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decision Quality Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment success rate of esophageal motility disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome - Joint Replacement Score (KOOS-JR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time of onset of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in the Behavior Assessment System for Children (BASC) from Baseline to Post Intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Engagement versus Disaffection with Learning from Baseline to Post Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: post-operative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acceptability of the intervention and participants' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability and practicability of intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of grade 3 or greater treatment-related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Level of Trust in the Video
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of 1-minute test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of 24-hour test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine concentration of methylprednisone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine concentration of methylprednisone metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine concentrations of deflazacort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine concentrations of deflazacort metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine concentration of dexamethasone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of people with obesity having Cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the liver steatosis grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) For Plasma Total Molybdenum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under The Plasma Concentration Versus Time Curve From Time 0 To The Last Quantifiable Concentration (AUCt) For Plasma Total Molybdenum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under The Plasma Concentration Versus Time Curve From Time 0 To Infinity (AUCinf) For Plasma Total Molybdenum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in plaque composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Depression before Transcranial direct current stimulation (tDCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Level of Anxiety before Transcranial direct current stimulation (tDCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intensity level of Depressive Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Freedom from MACE (Major Adverse Cardiac Events)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in serum carotenoid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum anthocyanin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of SENS-501 assessed by ABR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of SENS-501
Endpoint domain: Adverse events/effects
Primary endpoint: Child Percent of the 95th Body Mass Index Percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of utilization of physical restraints
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Side Bridge Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapular Endurance Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seated Medicine Ball Throw Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atorvastatin AUC(0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atorvastatin AUC(0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rosuvastatin AUC(0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rosuvastatin AUC(0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle thickness of the vastus lateralis quadriceps with ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PK trough of CAB LA measured in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of adults with at least one Grade 3 or higher adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of adults with at least one serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of dermal povorcitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of plasma povorcitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in omega-6/omega-3 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Schizophrenia Proneness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low density Lipoprotein-Cholesterol (LDL-C) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reductions in Low density Lipoprotein-Cholesterol (LDL-C) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Scale (VAS) Score Evaluating Relevance of Decision Factors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: long term social activity and social participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Children's Sleep Habits Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Proportion of Children with Correct management of oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Location of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Residual prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detectability of infective endocarditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Suicide Attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Penetration Efficiency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Yield of granulomatous inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain-free sitting time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain according to NRS during injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of moderate to severe primary graft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in caregiver-reported pain communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in pain management discussions with health care providers
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in concordance between patient and caregiver pain ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TACE Progression-Free Survival (TACE PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Agreement of severity codes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QPOP applicability
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CURATE.AI applicability
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical status assessed by a 6-point ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Type 3 or 5 treatment-emergent bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Retinal vessel leakage by automated segmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal vessel leakage by manual grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin depigmenting evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin whitening/brightening evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline Insulin Sensitivity at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Beta-cell Function at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Bone Mineral Density at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression Changes from Baseline Psychological Questionnaires at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety Changes from Baseline Psychological Questionnaires at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in facial skin characteristics as measured by the Fitzpatrick Wrinkle Scale (FWAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in facial skin characteristics as measured by the Skin Quality Assessment (SQA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Self esteem as measured by the Heatherton and Polivy State Self Esteem Scale (SESS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients reaching target systolic blood pressure range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in exercise capacity: peak oxygen uptake (VO2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in exercise capacity: workload (Watt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in exercise capacity: anaerobic threshold (AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target-to-background ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postural Sway Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of the respiratory quotient during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in plasma levels of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in plasma levels of marker of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in biopsy mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the mean systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in the mean diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes